Skip to main content
Caplight Logo









COGNANO, Inc.

COGNANO, Inc.

Private
KyotoHealthcare & Life Scienceshttps://cognano.co.jp

Momentum

Top 50%

of companies Caplight tracks

Company Overview

COGNANO, Inc. operates in Healthcare & Life Sciences and is based in Kyoto. It was founded in 2014.

COGNANO, Inc. is a biotechnology company that develops an AI-driven drug discovery platform by leveraging large-scale VHH antibody data derived from alpacas.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

COGNANO, Inc. Comparables

Compare COGNANO, Inc. with similar companies based on industry and business-model similarity.

COGNANO, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Order-made Medical Research Inc.
77%
Biocytogen
75%
Sanofi
72%
Book a demo to see all comparables

For institutional investors. Book with your work email.

COGNANO, Inc. Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for COGNANO, Inc.. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Akihiro Imura

代表取締役CEO

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 191% MoM, from 1K to 3K.

  • Jun 2, 2025

    Monthly visitors grew 183% MoM, from 1.2K to 3.4K.

Book a demo to see all signals

For institutional investors. Book with your work email.

COGNANO, Inc. Filings

Explore SEC and related filing metadata, where available.

COGNANO, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about COGNANO, Inc.'s valuation, stock price, and market status.

Is COGNANO, Inc. a public or private company?

COGNANO, Inc. is a private company.

What is the current stock price of COGNANO, Inc.?

COGNANO, Inc. is a private company, so its shares have no public market price. Caplight tracks COGNANO, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is COGNANO, Inc. worth (valuation)?

Valuation information for COGNANO, Inc. is not publicly available.

Can I buy COGNANO, Inc. stock?

COGNANO, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was COGNANO, Inc.'s last funding round?

Funding round information for COGNANO, Inc. is not publicly available.

Who are the main investors in COGNANO, Inc.?

Investor information for COGNANO, Inc. is not publicly disclosed.

Will COGNANO, Inc. IPO soon?

No public IPO plans have been announced for COGNANO, Inc..

How can I track COGNANO, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in COGNANO, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersKyoto
Employee Range8
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?